HomeLRMR • NASDAQ
add
Larimar Therapeutics Inc
Previous close
$3.53
Day range
$3.53 - $3.62
Year range
$1.61 - $6.91
Market cap
309.41M USD
Avg Volume
1.61M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 49.50M | 171.02% |
Net income | -47.71M | -207.84% |
Net profit margin | — | — |
Earnings per share | -0.61 | -154.17% |
EBITDA | -49.41M | -171.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 175.44M | -13.88% |
Total assets | 187.35M | -14.46% |
Total liabilities | 48.31M | 134.29% |
Total equity | 139.04M | — |
Shares outstanding | 85.59M | — |
Price to book | 2.18 | — |
Return on assets | -73.37% | — |
Return on capital | -92.40% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -47.71M | -207.84% |
Cash from operations | -28.75M | -17.14% |
Cash from investing | 33.02M | 21.07% |
Cash from financing | 65.29M | 217,523.33% |
Net change in cash | 69.55M | 2,423.69% |
Free cash flow | -11.40M | 39.48% |
About
Founded
2005
Headquarters
Website
Employees
65
